Hill-Rom Synclara PSC1, Руководство пользователя

Страница: 10 / 110

2 Synclara™ Cough System, Model PSC1 User Manual (196286 REV E)
Important Information
shifts to supply negative exsufflatory pressure (Exhale) with the intended
goal of rapidly deflating the lungs to simulate a high expiratory flow
which stimulates an effective cough. After exhale, the system moves into a
paused state and maintains a positive pressure flow to the patient, if
programed. This is referred to as Positive Airway Pressure on Pause (PAP).
An optional Sigh stage can also be included after the therapy to inflate the
patient’s lungs after the last exhale of the therapy.
I
NDICATIONS FOR
U
SE
The Synclara™ Cough System is indicated for, but is not limited to
patients with these conditions:
• Muscular dystrophy
• Spinal muscular atrophy
• Amyotrophic lateral sclerosis
• Spinal cord injuries
• Myasthenia gravis
• Post polio
• COPD patient with a weak and ineffective cough
C
ONTRAINDICATIONS
CONTRAINDICATION:
Contraindication —If patient conditions exist that cause the use of the
system to be a risk to the patient, do not use the unit. Death or serious
injury could occur.
A
BSOLUTE
C
ONTRAINDICATIONS
The Synclara™ Cough System is contraindicated if these patient conditions
exist:
• History of bullous emphysema, known susceptibility to
pneumothorax, or pneumo-mediastinum, or known to have had any
recent barotraumas
• Severe airway obstruction
Draft_E_2019-Apr-29_Cleaned